Home > Insider Trading > Filing (0001209191-15-067793)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326110	Nantkwest Inc.	NK	Biological Products, (No Disgnostic Substances) (2836)	431979754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189020	Patrick Soon-Shiong	C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121	Chairman And Ceo	Yes	Yes	Yes	No
1629186	Mp 13 Ventures, Llc	C/O Nantkwest, Inc. 2533 South Coast Highway 101, Suite 210 Cardiff-By-The-Sea CA 92007-2133		No	No	Yes	No
1629222	Cambridge Equities, Lp	C/O Nantkwest, Inc. 2533 South Coast Highway 101, Suite 210 Cardiff-By-The-Sea CA 92007-2133		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-21	450,000	$23.00	41,016,557	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	600,000	Direct

Footnotes

Shares held by Cambridge Equities, LP ("Cambridge Equities"). MP 13 Ventures, LLC ("MP 13 Ventures") is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the shares held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the shares held by Cambridge Equities.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock. Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs will vest as follows: 50% of the RSUs vested on the July 27, 2015, and 50% of the RSUs will vest on July 27, 2016.